Status:
RECRUITING
Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis
Lead Sponsor:
IRCCS Sacro Cuore Don Calabria di Negrar
Collaborating Sponsors:
Leiden University Medical Center (LUMC)
Conditions:
Schistosomiasis
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
The primary objective of this clinical investigation is to determine the percentage of travelers and migrants diagnosed with chronic schistosomiasis according to site-specific diagnostic practice who ...
Eligibility Criteria
Inclusion
- Inclusion criteria
- diagnosis of chronic schistosomiasis (\>3 months after last potential exposure) according to site-specific diagnostic practice
- signed informed consent (and assent for minors).
- Exclusion criteria
- age below 5 years;
- exposure to praziquantel after the last potential exposure to schistosomes
- acute infection, i.e. likely infection \<3 months before presentation
Exclusion
Key Trial Info
Start Date :
June 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT06873308
Start Date
June 28 2024
End Date
January 1 2027
Last Update
April 20 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Tropical Medicine (ITM)
Antwerp, Belgium
2
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
3
IRCCS Policlinico Sant'Orsola
Bologna, BO, Italy
4
IRCCS Sacro Cuore Don Calabria
Negrar, VR, Italy, 37024